Form 4: Encompass Health Corp Executive Elissa Charbonneau Reports Stock Transaction

Elissa Charbonneau, Chief Medical Officer of Encompass Health Corp, reported a transaction involving the withholding of 2,991 shares of common stock to cover tax obligations.

Summary

• Elissa Charbonneau, the Chief Medical Officer of Encompass Health Corp, filed a Form 4 indicating a transaction on January 1, 2025.
• The transaction involved the withholding of 2,991 shares of Encompass Health common stock.
• These shares were used to cover tax obligations related to the vesting of restricted stock.
• Following the transaction, Ms. Charbonneau directly owns 15,603.061 shares of Encompass Health common stock.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing of an insider transaction, which is neither positive nor negative for the company's overall performance.

Industry Context

This is a routine filing related to insider transactions and is common for executives who receive stock-based compensation.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this transaction is typical for executives receiving stock-based compensation.
• Similar filings are made by executives at companies like Select Medical Holdings Corporation and Tenet Healthcare Corporation when they have stock transactions.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine tax withholding event.

Key Dates

Keywords

Form 4, insider trading, stock transaction, Encompass Health Corp, Elissa Charbonneau, Chief Medical Officer, tax withholding, restricted stock